Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer

Update: 2009-05-14

Description

Dr. Michael Cleary discusses this work on the role of chromosomal aberrations in causing cancer and its implications for cancer treatment. (September 18, 2008)

Comments

In Channel

Pharmacogenomics of Cancer

2009-05-1400:02

Hedgehog Signaling and Cancer: New Concepts and Therapeutic Opportunities

2009-05-1400:02

Hodgkin's Disease: A Paradigm for Clinical Research

2009-05-1400:02

Targeted Anticancer Therapies

2009-05-1400:03

Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer

2009-05-1400:02

Gynecologic Cancers: Translational Research Opportunities

2009-05-1400:03

Translational Research in Acute Leukemia

2009-05-1400:02

Translational Cancer Research in Urological Malignancies

2009-05-1400:01

Imaging of Immune Cell Trafficking Patterns Refines Development of Cell-Based Therapies

2009-05-1400:02

Assessing Genetic Risk for Cancer: Stanford Clinical Cancer Genetics Program

2009-05-1400:02

Targeted Therapy and Vaccines for Breast Cancer

2009-05-1400:02

The Ethical Conduct of Research

2009-05-1400:02

Breast Cancer Prevention Studies

2009-05-1400:02

Head and Neck Cancer

2009-05-1400:01

Pediatrics Cancer

2009-05-1400:02

Hematopoietic and Leukemic Stem Cells

2009-05-1400:03

Cancer and Regenerative Medicine

2009-05-1400:02

Stem Cell Transplantation and Induction of Tolerance

2009-05-1400:01

Dendritic Cell Therapy

2009-05-1400:02

Oncogenes and Cancer: Oncogene Addition, the Achilles Heal of Cancer

2009-05-1400:02

00:00

1.0x

Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer

#box-pro-ellipsis-175885617799099{-webkit-line-clamp:2;}Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer

Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer

Stanford University

Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer